Myriad Genetics (MYGN) PT Lowered to $20 at Piper Sandler
Piper Sandler analyst William Quirk ...
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
(Premium-only article. Please sign in or upgrade to SI Premium to view.)
